ATE500271T1 - Fluoresceinmarkierte peptide - Google Patents

Fluoresceinmarkierte peptide

Info

Publication number
ATE500271T1
ATE500271T1 AT04748784T AT04748784T ATE500271T1 AT E500271 T1 ATE500271 T1 AT E500271T1 AT 04748784 T AT04748784 T AT 04748784T AT 04748784 T AT04748784 T AT 04748784T AT E500271 T1 ATE500271 T1 AT E500271T1
Authority
AT
Austria
Prior art keywords
labeled peptides
fluorescein labeled
angiogenesis
optical imaging
relates
Prior art date
Application number
AT04748784T
Other languages
English (en)
Inventor
Alan Cuthbertson
Bard Indrevoll
Magne Solbakken
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE500271T1 publication Critical patent/ATE500271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04748784T 2003-07-08 2004-07-07 Fluoresceinmarkierte peptide ATE500271T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20033115A NO20033115D0 (no) 2003-07-08 2003-07-08 Peptid-baserte forbindelser
PCT/NO2004/000208 WO2005003166A1 (en) 2003-07-08 2004-07-07 Fluorescein-labelled peptides

Publications (1)

Publication Number Publication Date
ATE500271T1 true ATE500271T1 (de) 2011-03-15

Family

ID=27800789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748784T ATE500271T1 (de) 2003-07-08 2004-07-07 Fluoresceinmarkierte peptide

Country Status (9)

Country Link
US (1) US7608243B2 (de)
EP (1) EP1639004B1 (de)
JP (1) JP4993463B2 (de)
CN (1) CN1820025A (de)
AT (1) ATE500271T1 (de)
DE (1) DE602004031617D1 (de)
ES (1) ES2361670T3 (de)
NO (2) NO20033115D0 (de)
WO (1) WO2005003166A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2405469C (en) * 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
NO20035683D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av prostatakreft
NO20035681D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft
RU2393167C2 (ru) * 2004-06-16 2010-06-27 Джи-И Хелткер АС Пептидные соединения
JP5280682B2 (ja) * 2004-06-16 2013-09-04 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチド系化合物
DE602005025911D1 (de) * 2004-11-22 2011-02-24 Ge Healthcare As Kontrastmittel für eine extrazelluläre matrix
GB0428012D0 (en) 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
EP1833512A1 (de) * 2005-01-06 2007-09-19 GE Healthcare AS Optische bilddarstellung
EP2299277B1 (de) 2009-09-17 2015-10-21 F. Hoffmann-La Roche AG Analysesystem zur Analyse biologischer Proben, Verfahren und Computerprogrammprodukt
PL238871B1 (pl) * 2018-02-13 2021-10-18 Univ Gdanski Peptydomimetyk oraz jego zastosowanie jako środek fluorescencyjny in vitro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
DE19808591C2 (de) * 1998-02-28 2000-02-03 Univ Leipzig Standardisierter durchflußzytometrischer Vollblutassay
CA2405469C (en) 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
ES2361670T3 (es) 2011-06-21
US7608243B2 (en) 2009-10-27
US20070183977A1 (en) 2007-08-09
NO20033115D0 (no) 2003-07-08
EP1639004A1 (de) 2006-03-29
JP4993463B2 (ja) 2012-08-08
DE602004031617D1 (de) 2011-04-14
CN1820025A (zh) 2006-08-16
JP2007528846A (ja) 2007-10-18
WO2005003166A1 (en) 2005-01-13
EP1639004B1 (de) 2011-03-02
NO20056055L (no) 2006-02-13
NO332926B1 (no) 2013-02-04

Similar Documents

Publication Publication Date Title
Akcan et al. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy
ATE442379T1 (de) Bildgebende agentien auf basis bizyklischer peptide
PL1765863T3 (pl) Związki oparte na peptydach
Soudy et al. Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer
Kuil et al. Imaging agents for the chemokine receptor 4 (CXCR4)
DK1272507T3 (da) Integrinbindende peptidderivater
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
ATE500271T1 (de) Fluoresceinmarkierte peptide
MXPA04000173A (es) Compuestos basados en peptidos.
UA109633C2 (uk) Антитіло людини проти тканинного фактора
PT907379E (pt) Agentes de contraste bioactivados para imagiologia de diagnostico
EA200971130A1 (ru) Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
ATE519776T1 (de) Peptidische verbindungen
AR047729A1 (es) Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe)
GT201000148A (es) Anticuerpos antimesotelina y usos de los mismos
EA200870502A1 (ru) Белки слияния на основе rage, их композиции и способы их применения
CY1115316T1 (el) Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων
CR8230A (es) Sondas para enfermedades en las cuales se acumula amiloide, agentes para tincion del amiloide, farmacos para tratamiento y profilaxis de enfermedades con amiloide acumulado y sondas para diagnostico de ovillos neuro fibrilares yagentes...
ATE509949T1 (de) Metastasisch spezifische peptide und ihre diagnostischen und therapeutischen anwendungen
DE50205029D1 (de) Entzündungsspezifische peptide und deren verwendungen
DE602006017964D1 (de) Ephb-rezeptorbindende peptide
ATE551357T1 (de) Markerpeptid für die alzheimer-krankheit
EA200501711A1 (ru) Семейство секретируемых белков
ATE480552T1 (de) Stq-peptide
NO20065806L (no) Peptid-baserte forbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties